Participation

a) Presentations:

Have given many international papers presentations in American Society of Clinical Oncology (ASCO), International Society of Pediatric Oncology (SIOP), SNM (International Society of Nuclear Medicine) and had invited talks in eight countries.

Papers presented at conferences:

International

1. Oral Presentation: Connective Tissue Oncology Society (CTOS-2022)annual congress-Vancouer, Canada,  – sarcoma of the year session –Low cost metronomic therapy as a sustainable care for Fibromatosis
2. Breakout session chair and presenter –Global AYA congress 2023, long beach Californea, June 2023“Bridging the Divide: Care Patterns and Focus Areas for Adolescents and Young Adults”
3. Poster Presentation: Connective Tissue Oncology Society (CTOS -2022)annual congress-Vancouer, Canada
4. Poster Presentation: best poster award –AYA category-CTOS -2022 demographics, practice patterns, challenges and outcomes of synovial sarcoma patients from a tertiary care centre from a large low-middle income country abstract ID:
5. Poster presentation: ESMO Asia, 2022 Singapore - Alveolar soft part sarcoma : experience from atertiary care centre in India.
6. Poster presentation : ESMO, Paris , 2022- Epidemiology of rare cancers from SAARC countries –remembering the forgotten
7. Poster presentation –ESMO 2021; Ewings sarcoma outcomes: experience from a tertiary care centre in India.
8. Poster Presentation: European Society of Medical Oncology Breast (ESMO 2020): Pregnancy Associated Breast Cancer: Report from a gestational cancer registry from a tertiary care cancer center, India.
9. Poster Presentation: European Society of Medical Oncology Breast (ESMO 2020): Young Breast Cancer: Report from a cancer registry from a tertiary care cancer center, India.
10. Poster with discussion: 48th Congress of the International Society of Paediatric Oncology (October 19-22, 2016 in Dublin, Ireland) “Non- High dose- Methotrexate (HD-MTX) based, dose-dense (DD), combination, chemotherapy (CT) in 243 Non-metastatic osteosarcoma patients”: A tertiary care centre experience from India.
11. Poster Presentation: 48th Congress of the International Society of Paediatric Oncology (2016 in Dublin, Ireland). “Non- High dose–methotrexate (HD-MTX) based, dose-dense (DD), combination, chemotherapy (CT) in 83 metastatic osteosarcoma patients: A tertiary care centre experience from India”.
12. Poster Presentation: Third ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland, November 2016. Clinical profile and outcome of PABC patients in a tertiary care center in India
13. Poster Presentation: European Cancer Congress, ESMO, Vienna-Austria 2015“Everolimus in heavily pre-treated metastatic breast cancer (MBC): is real (developing) world experience different?”
14. Poster with discussion: 47th Congress of the International Society of Paediatric Oncology (Cape Town, South Africa) “Non- high dose-methotrexate (HD-MTX) based dose-dense (DD) chemotherapy (CT) in osteosarcoma: Is it effective, economic and easy?”
15. Poster Presentation: 47th Congress of the International Society of Paediatric Oncology, Cape Town, South Africa “Demographic profile and predictors for chemo toxicity in osteosarcoma: A tertiary care center experience from India?”
16. Poster Presentation: American Society of Clinical Oncology 2014, Chicago, Illinois, USA. Bajpai J et al. “Is non-HD-MTX based, dose-dense, combination chemotherapy a valid choice in osteosarcoma in developing world?” May 30 – June 3, 2014.
17. Poster Presentation: 46th Congress of the International Society of Paediatric Oncology (SIOP), Toronto, Canada.Bajpai J et al. Is Non-high dose–methotrexate (HD-MTX) based, dose-dense (DD), combination chemotherapy (CT) a valid choice in> high tumor burden and nutritionally challenged osteosarcoma? 22-25th October 2014.
18. Ghosh J,…Bajpai J[..], RA Badwe, Abstract P4-14-07: Outcome with use of 12 weeks of adjuvant or neoadjuvant trastuzumab in a resource constrained setting: DOI: 10.1158/1538-7445.SABCS15-P4-14-07
19. Rekhi B, Ramadwar M, Bajpai J. Extraskeletal Myxoid Chondrosarcomas Are Not Characterized by Loss of INI1/SMARCB1: Immunohistochemical Analysis of 12 Cases Arch Pathol Lab Med2016; 140: e174. Poster No. 184
20. MahantshettyU , S. Shrivastava U , ..., Bajpai J et al ..ESGO7-1305 Cisplatin Chemo-Radiation Versus Radiation in Figo Stage IIIb Squamous Cell Carcinoma of the Uterine Cervix (CRACX TRIAL: NCT00193791)

National

1. Sujeeth M, Bajpai J et al. Pazopanib in advanced soft tissue sarcomas: first data from India. ISMPO con New Delhi, November 2016.
2. Woman’s Cancer initiative 2014: “Poster presentations for National Pregnancy Associated Breast Cancer Registry”
3. Woman’s Cancer initiative 2014: “Poster presentations for “Co morbidity Burden in Breast cancer”

b) Awards:

1. Sarcoma of the year session CTOS -2022
   • Oral Presentation: Connective Tissue Oncology Society (CTOS-2022)annual congress-Vancouer, Canada,  ––Low cost metronomic therapy as a sustainable care for Fibromatosis Abstract ID: 1301107
2. Best poster award CTOS
   • Connective tissue Oncoloy Society -2022– AYA category: Vancouer, Canada.Outcomes, prognostic factors and treatment compliance in osteosarcoma cases treated with an indigenous, low-cost protocol, ogs-12, in a tertiary care cancer centre in india. abstract id: 1301438
3. Breakout session–Global AYA congress 2023
   • Long beach California, June 2023“Bridging the Divide: Care Patterns and Focus Areas for Adolescents and Young Adults”
4. Best paper award: 
   • Global Breast Cancer Conference (GBCC) 2019, Incheon, Korea: “Demographic profile and outcomes of pregnancy associated breast cancer (PABC) patients in a tertiary care center in India”.
5. Best poster award: SIOP
   • Poster Presentation: 46th Congress of the International Society of Paediatric Oncology (SIOP-2014), Toronto, Canada. Bajpai J et al.Is non-high dose–methotrexate (HD-MTX) based, dose-dense, combination chemotherapy (CT) a valid choice in high tumor burden and nutritionally challenged osteosarcoma?
6. Best project award:
   • Australia and Asia pacific clinical oncology research development (ACORD) workshop.A Double Blind Randomized Controlled Trial of Renal Protective Effects of Normal Saline Plus Placebo Versus Normal Saline Plus Mannitol Prior to Cisplatin Containing Chemotherapy Regimens in Solid Tumors.
7. Indo-American Cancer Association (IACA) grant for Melanoma and Immuno-Oncology observership under International Observership Programme in Memorial Sloan Kettering Cancer Center (MSKCC), Manhattan, New York City, United States, 2018
8. Women Lift Health Leadership Journey programme –selected for India Cohort -2023

c) Invited International Faculty:

1. Steering committee EURACAN –with the sidelines of ESMO sarcoma and rare cancer congress , Lugano., March 19, 2023.
2. Invited expert/faculty for Desmoid Tumour consensus meeting June 30, 2023, Milan
3. Breakout session chair and presenter –Global AYA congress , long beach California, June 2023
4. Invited faculty for European Society for Medical Oncology (ESMO) Vascular Sarcoma and Consensus Meeting on Sarcoma and GIST, as a faculty, and guideline committee member, Milan, 3rd - 5th Dec, 2020.
5. Invited faculty for Immunotherapy of Cancer (SITC) for Women in Cancer Immunotherapy (WIN), Seattle, and 19th – 20^th Aug, 2019.
6. Invited for World Immuno-council (WIC)/ Society of Immunotherapy of Cancer (SITC) as a senior investigator and mentor for young investigator‘s for Oral Presentation: The clinical utility and safety of Immune check point inhibitors (ICI) - Multicentre data from India conducted in the United States of America (USA), invited as a Senior Investigator/Corresponding author of the paper presentation from 6th -8th November, 2019.
7. Invited faculty for European Society of Medical Oncology: leadership generation Programme (ESMO-LGP) as a mentor and Speaker: ESMO-LGP-What it brought to me!
8. Invited faculty for European Society of Medical Oncology: leadership generation Programme (ESMO-LGP) as a panelist for Women in oncology- Singapore from 18th-21st November, 2019.
9. Invited faculty for European society of Medical Oncology-Asia (ESMO-Asia) for Speaker- Mentorship: Young Oncology Track, Poster: Women in Oncology in India-Alarming figures as a faculty, Speaker and poster presentation, Singapore from 22nd -24th November, 2019.
10. Received Indo-American Cancer Association (IACA) grant for Melanoma and Immuno-Oncology observership under International Observership Programme in Memorial Sloan
11. Kettering Cancer Center (MSKCC), Manhattan, New York City, United States, 2018.
12. Invited faculty for Immunotherapy of Cancer (SITC) for Women in Cancer Immunotherapy (WIN), Seattle, Aug, 2021.
13. Invited faculty for upcoming European society of Medical Oncology-Asia (ESMO-Asia) for Speaker 2021
14. Global Adolescent and Young Adult(AYA) Cancer Congress meeting invited as speaker and chair for breakout session, California (USA)- 20/06/2023- 23/06/2023
15. Desmoid-tumor consensus meeting of global experts organised by Desmoid-tumour Foundation (DTF)as a subject expert and panel member, Virtual/Milan- 2023 June
16. Pan Asian GuidelinesAdaptation (PAGA)breast cancer guidelines expert panel, ESMO, ISMPO and other Asian societies as a subject expert and panel member, Virtual/Seoul- 2023 Sep
17. SITC Advanced Webinar for LMICs: Gynecologic Clinical Practice Guideline as a organizer and faculty, Virtual-2023 Nov
18. Advanced Breast Cancer Seventh International Consensus Conference (ABC7) invited as subject expert and panel member, Lisbon, Portugal - 9/11/2023- 11 /11/2023
19. Tenosynovial Giant Cell Tumour (TGCT) Consensus meeting, Euronetinvited as a subject expert and panel member, Frankfurt Germany- 21/06/2022- 21/06/2022
20. Society for Immunotherapy of Cancer (SITC) guidelines, Women in Cancer Immunotherapy Network (WIN) invited as apanel member, Seattle USA- 27/07/2022- 29/07/2022
21. Connective Tissue Oncology Society (CTOS) Annual Meeting, invited as a chair subject expert and panel member desmoid-tumour oral (sarcoma of the year session) and poster presenter, Vancouver Canada- 14/11/2022- 21/11/2022
22. Society of Immunotherapy of cancer (SITC) Gynecologic Cancers Immunotherapy Guideline Expert Panel,Virtual meeting- 2022 July
23. European society of Medical Oncology-Asia (ESMO-Asia) invited as a Speaker, panel & discussant, Singapore- December 2022
24. Invited for World Immunocouncil (WIC)/ Society of Immunotherapy of Cancer (SITC, Senior investigator, San Diego, CA USA,Virtual meeting- November 2023
25. 1^st Global Virtual Women for Oncology Summit(GLOWS), Women for Oncology –SAARC nations and W4O –India and Egypt, organising chair, faculty & moderator, virtual meeting- August 2022
26. Ultra-rare sarcomas: consensus meeting of expertsCTOS (to evaluate the minimum requirements for the evaluation of activity of systemic treatments in retrospective observational studies), Connective Tissue Oncology Society (CTOS), subject expert and panel member,virtual meeting- 2022

d) Membership International bodies

1. Member of ESMO (European Society of Medical Oncology)
2. Member of ASCO (American Society of Clinical Oncology)
3. Member of SITC (Society of Immunotherapy of Cancer)

e) Achievements/Positions:

National

1. Founder General Secretary: Immuno-Oncology Society of India (IOSI)
2. Executive member –Indian Society of Medical and Pediatric Oncology (ISMPO)
3. Founder chair for Women for Oncology -India (under the banner of ISMPO)
4. Founder Member and current Joint Secretary: Teenage and Young Cancer Association (TYA)
5. Breast disease management group, Tata Memorial Centre –secretary-2021-22
6. Breast disease management group, Tata Memorial Centre –Convenor-2022-till date
7. Member of IMSOS (Indian Musculoskeletal Oncology Society)
8. Member of Indian association of Palliative Care

f) Editorial Positions:

International: Editorial Board Member

• Journal of Immunotherapy and Precision Oncology (JIPO) -MD Anderson affiliated Journal
• Frontiers in oncology –breast section

National:

Joint Editor Indian Journal of Medical and Pediatric Oncology (IJMPO):

Editorial Board member: South Asian Journal of Cancer (SAJC).

Examiner-Super specialty exams /MCI evaluator

1. External Examiner for the Practical and Viva-Voce of Super-Specialty (M.Ch./D.M.) Examination held by Madhya Pradesh Medical Science University, Jabalpur (MP.):2019
2. External Examiner for super specialty exam (DM Medical Oncology) at Gujarat Cancer Research Institute:2019
3. MCI inspector for SVIMS, Tirupati, Andhra Pradesh, 2019. External Examiner for the Practical and Viva-Voce of Super-Specialty (M.Ch./D.M.) Examination held by Madhya Pradesh Medical Science University, Jabalpur (MP.) for Aribindo medical college :2019
4. External Examiner for the Practical and Viva-Voce of Super-Specialty (M.Ch./D.M.) Examination held by SVIMS, Tirupati medical college :2020
5. External Evaluator /Examiner for thesis for Super-Specialty (M.Ch./D.M.) Examination for GCRI University.2020
6. External Examiner for the Practical and Viva-Voce of Super-Specialty (M.Ch./D.M.) Examination held by Madhya Pradesh Medical Science University, Jabalpur (MP.):2020
7. External Examiner for the Practical and Viva-Voce of Super-Specialty (M.Ch./D.M.) Examination held by Madhya Pradesh Medical Science University, Jabalpur (MP.):2021